Table 1 In-hospital patient characteristics
From: Cardiovascular secondary prevention in high-risk patients: a randomized controlled trial sub-study
Intervention | Control | |
|---|---|---|
n = 225 | n = 215 | |
Age in years, median (25th–75th percentile) | 75 (67–82) | 75 (67–80) |
Female, n (%) | 86 (38.2) | 75 (34.9) |
Smoking, n (%) | 25 (11.1) | 23 (10.7) |
BMI, median (25th–75th percentile) | 27.9 (24.7–31.0) | 27.2 (24.6–30.2) |
Diabetes mellitus, n (%) | 139 (61.8) | 128 (59.5) |
Chronic kidney disease, n (%) | 121 (53.8) | 123 (57.2) |
Prior disease, n (%) | ||
Coronary artery disease | 52 (23.1) | 57 (26.5) |
Stroke/TIA | 52 (23.1) | 44 (20.5) |
Peripheral artery disease | 8 (3.6) | 9 (4.2) |
Qualifying event, n (%) | ||
Unstable angina | 7 (3.1) | 9 (4.2) |
NSTEMI | 82 (36.4) | 70 (32.6) |
STEMI | 30 (13.3) | 24 (11.2) |
TIA | 35 (15.6) | 42 (19.5) |
Ischemic stroke | 68 (30.2) | 66 (30.7) |
Haemorrhagic stroke | 3 (1.3) | 4 (1.9) |
Treatment at admission, n (%) | ||
Antihypertensive drug (≥1) | 183 (81.3) | 188 (87.4) |
Lipid-lowering drug | 92 (40.9) | 113 (52.6) |
Treatment at discharge, n (%) | ||
Antihypertensive drug (≥1) | 211 (93.8) | 199 (92.6) |
Lipid-lowering drug | 185 (82.2) | 180 (83.7) |